CSPC Pharmaceutical’s SYS6010 gets Breakthrough Therapy designation
CSPC Pharmaceutical said SYS6010 was granted Breakthrough Therapy designation by the NMPA.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.